The ruling from Judge Robert Drain stays action for three weeks in state and federal lawsuits against the drugmaker and its owners. Purdue Pharma had asked for a six-month reprieve.
During the three-week stay, Purdue Pharma agreed to provide state attorneys general more information about the Sackler family’s finances.
The drugmaker argued that halting litigation was necessary to allow progress on a tentative settlement with more than 2,600 plaintiffs who have accused Purdue Pharma of fueling the opioid epidemic by hiding the addiction risks of OxyContin.
Purdue Pharma told The Post the judge’s decision “is an essential next step in preserving Purdue’s assets for the ultimate benefit of the American public. The company will work tirelessly and collaboratively during this pause in the litigation to continue to build support for the settlement structure.”
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.